Bovine Blood Plasma Derivatives Market

Bovine Blood Plasma Derivatives Market Product (Kits and Reagent, Instruments and Software and Service), Derivatives Type (Fetal Bovine Serum, Fibrinogen, Immunoglobulin, Serum Albumin, Thrombin, and Transferrin), Source (US Grade, New-Zealand Grade, Australia Grade, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Bovine Blood Plasma Derivatives Market Outlook 2034

  • The global bovine blood plasma derivatives industry was valued at US$ 2.0 Bn in 2023
  • The bovine blood plasma derivatives market is projected to grow at a whopping CAGR of 5.8% from 2024 to 2034 and reach more than US$ 3.7 Bn by the end of 2034

Analysts’ Viewpoint

Bovine blood plasma derivatives are experiencing phenomenal growth owing to their demand in industries such as pharmaceuticals, nutritional, and agriculture. Growth is positivity allied to greater use from therapeutic applications and the production of vaccines for which the derivatives concerned are assessed to possess high bioactivity and rich protein content.

Overall, key trends governing the bovine blood plasma derivatives market include improvement in the plasma processing value chain and higher demand for traceable, high-quality blood plasma products.

Bovine blood plasma derivatives are essential in pharmaceutical applications for a range of conditions; such as, they contribute to exponential growth in this market. Their nutritional applications, for example in sports nutrition and finishing touches in infant formula, similarly continue to grow given their higher nutritional value.

In addition to this, the agriculture industry works by utilizing such by-products as key formulation components in animal feed. The bovine blood plasma derivatives market is driven in the forecast period by innovations in processing and an increase in demand across multiple industries.

However, this growth is constrained by factors such as regulatory scrutiny and ethical concerns around sourcing. Overall, the outlook for this market continues to be bright, with ongoing research and development activities furthering applications and efficiency in products developed.

Bovine Blood Plasma Derivatives Market Outlook

The growth of the bovine blood plasma derivatives market is attributed to high demand from the animal feed industry and growing demand from functional food industries. Bovine plasma protein derivatives, like spray-dried and hydrolyzed bovine plasma proteins for enhancing feed quality and animal health, are playing an important role here.

For example, spray-dried plasma proteins greatly enhance the production of milk in dairy cows without affecting the reproductive health of the cow, while hydrolyzed plasma helps in reducing post-weaning diarrhea and improving growth performance in pigs.

Animal feed industry is one of the key drivers in the growth of the bovine blood plasma derivatives market. According to the Institute for Feed Education and Research, the U.S. alone witnessed a high consumption level of the ingredient in 2019, mainly consumed by beef cattle, hogs, and broiler chicken.

This interest is supported by the fact that global feed production continues to increase, recording a 1% growth in 2020 to about 1,187.7 million metric tons, according to Alltech's Global Feed Survey, indicating increasing demand for premium feed ingredients like bovine plasma derivatives.

Furthermore, bovine blood plasma proteins are used in nutritional enhancement in food and beverages. The development regarding collection and processing of blood has enabled the inclusion of proteins in functional foods and nutritional supplements. The high digestibility and economic viability of the proteins further make them an excellent substitute for traditional ingredients in baked products, such as eggs.

With further innovations in processing technologies and an increase in demand for animal feed and nutritional supplements, the prospects of the future market look very encouraging. In contrast, this industry will also have challenges to tackle in terms of verdicts regarding regulatory standards and sourcing ethics.

Overall, the bovine blood plasma derivatives market will expand significantly with its versatile applications and the rising demand for high-quality protein sources.

Attribute Detail
Bovine Blood Plasma Derivatives Market Drivers
  • Advances in Technology for Blood Collection and Processing
  • Increasing Demand for Advanced Drug Delivery Systems

Advances in Technology for Blood Collection and Processing contributing toward Bovine Blood Plasma Derivatives Market Growth

The bovine blood plasma derivatives market has been developing drastically with improvements in blood collection and processing technologies. In the past, blood collection for pharmaceutical and food ingredients had a minimal level of technological intervention.

Modern applications in diagnostics, serum media, and research require high-quality blood products. This has, in turn, led to the evolution of better methods of collection to ensure product integrity and safety. The modern technology in blood collection has been adopted across the advanced countries in Europe; primarily Germany and Scandinavia.

The semi-automatic process of blood collection used by most countries today was adapted from these countries. Fully automatic and semi-automatic systems are consistent, efficient, and of higher standards in blood collection.

Various blood collection systems can be provided by different suppliers in order to satisfy the demand for customized services. For instance, Butina AB (Sweden) offers specialized equipment: RotaStick bleeding carousel, intermediate storage RectaStore, BallTec plasma, and hemoglobin dryers.

These state-of-the-art systems fasten the speed of blood collection and processing, thereby increasing production capabilities for bovine blood derivatives. Advanced technologies that speed up the collection process also improve the overall quality of blood derivatives, which is necessary for high-level procurement for use in various medical and research applications.

This leads to increased bovine blood derivative production, hence meeting the increased demand by the pharmaceutical, diagnostic, and research sectors.

Increasing Demand for Advanced Drug Delivery Systems Propelling Bovine Blood Plasma Derivatives Market

The latest trend is that of the inclination of the pharmaceutical industry toward the development of advanced drug delivery system. The bovine blood plasma derivatives, majorly comprising albumin and immunoglobulins, see applications in the formulation of biopharmaceuticals and vaccines because of its unique biochemical property.

For instance, albumin is generally used as a stabilizer in drug formulations, usually added to such drugs to extend the shelf life and improve the therapeutic proteins and vaccines. This peculiar property of albumin of binding to different drugs and biologics makes it work as an excipient in the development of extended-release formulations for achievement of high level of patient compliance and betterment of therapeutic outcomes.

On the other hand, the increased demand for biologics and complex pharmaceuticals necessitating high-tech delivery mechanisms has accelerated the demand for quality plasma derivatives. These derivatives have become integral in the development of formulations providing control, targeted delivery, and protection of the active pharmaceutical ingredient (API) from degradation.

With continued innovation in areas such as Nan medicine, gene therapy, and personalized medicine within the pharmaceutical industry, demand for reliable excipients like bovine plasma derivatives will likely rise, further driving bovine blood plasma derivatives market expansion.

Moreover, the regulatory agencies' approval of bovine plasma derivatives in drug formulation has further boosted their adoption in the pharmaceutical industry. With safety profiles and claims in their functionality very well documented, they eventually turn out to be a preferred choice for drug developers when adhering to the strict quality and efficacy standards of drugs in use today.

The demand for bovine blood plasma derivatives is bound to grow with the growth of the pharmaceuticals industry across the world, especially in new markets.

Thrombin Dominating Global Market for Derivatives Type

By derivatives type, the thrombin segment is projected to dominate the global bovine blood plasma derivatives market during the forecast period. This dominance is attributed to its crucial role in surgical procedures and biomedical research.

Thrombin from bovine origin is a proteolytic enzyme with multifunctional activities that have typically been used as a drug for hemostasis during surgery, thereby proving to be an integral part of this field of medicine. For instance, thrombin turns the soluble plasma protein fibrinogen into fibrin, which forms the actual framework for a blood clot.

This is a critical action in controlling bleeding during surgeries, for example, liver resection, spinal procedures, and vascular surgeries like peripheral arterial bypass and dialysis access.

The high effectiveness of bovine thrombin in inducing rapid hemostasis has made it the agent of choice among surgeons worldwide. In a comparatively clinical trial, hemostasis at 10 minutes was achieved by bovine thrombin in 95% of patients. This inference underpins its efficiency in surgical settings.

Other than the surgical uses of bovine thrombin, this compound has some applications in the laboratory and research field.

According to WHO data 2023, more than 300 million surgeries are performed each year at the global level, and the number of surgical procedures performed around the world has increased dramatically over time.

As the number of surgical procedures increases, the demand for the use of bovine derivatives thrombin are also likely to increase during the forecast period. In addition, bovine thrombin can specifically cleave some proteins. Therefore, during the production of recombinant proteins, it is used in removing affinity tags from fusion proteins.

US Grade Leading Market by Source Segment in Bovine Blood Plasma Derivatives Market

The US grade segment is projected to dominate the global bovine blood plasma derivatives market during the forecast period. The dominance of this segment is a result of the superior quality and reliability of U.S.-origin bovine plasma for a wide range of medical and research applications.

Innovative Grade U.S. Origin Bovine Plasma is sourced from United States Department of Agriculture-approved facilities in the United States, assuring high-quality plasma. This rigid process of sourcing plasma ensures that the plasma is rich in valuable proteins such as albumin, immunoglobulins, complement, lipoproteins, and coagulation proteins for use in a wide range of applications.

Consistency and reliability make U.S.-origin bovine plasma the preferred choice for both: clinical and research settings. In coagulation assays, for example, the accurate measurement of the various blood factors that form clots is paramount to diagnosis and the management of bleeding disorders.

Plasma of high quality is necessary for accurate and reproducible results, which are important in terms of patient safety and effective treatment.

Besides, the pledge of quality in U.S.-origin bovine plasma products turns into dependable outcomes across a variety of applications-from diagnostics to biopharmaceutical production. Similarly, this reliability could explain the reason why U.S. grade bovine derivatives are dominant in the market, as it becomes an important attribute in the decision-making process of the stakeholders.

As various global markets give increasing priority to quality and consistency, the U.S.-origin bovine derivatives are in a position to lead bovine blood plasma derivatives market demand for a reliable source of high-quality plasma for a variety of medical and research applications. That trend signals how serious sourcing standards or production are in giving way to market leadership.

Regional Outlook of Bovine Blood Plasma Derivatives Industry

Attribute Detail
Leading Region North America

North America’s bovine blood plasma derivatives market is poised for significant growth due to several driving factors. The dominance of the region is driven by several key factors that enhance its market attractiveness. First, well-developed healthcare infrastructure with a considerable volume of surgical procedures insatiably contributes to generating demand for bovine blood plasma derivatives.

For instance, intraoperative bleeding is treated or prevented with bovine thrombin usage. According to the National Center for Health Statistics, approximately 1.2 million cholecystectomies are performed every year in the U.S, and the cesarean deliveries as a percentage of births was recorded at 32.1% in the year 2022.

Hence, this high frequency of surgeries doubles and triples the demand for hemostatic agents such as bovine thrombin, thereby driving the bovine blood plasma derivatives market growth. Worth mentioning here is that the growth of the North American Animal Nutrition Industry is also aiding the market expansion.

Contributions the American Feed Industry Association made to the U.S. economy totaled more than $267 billion in 2022. Its counterpart, the 2022 Global Feed Survey and Agri-Food Outlook from Alltech, estimated the North American production volume for 2021 pet food at 10.6 million metric tons. This represented an increase of 12.7% over the prior year and the highest growth of any feed sector.

Bovine blood plasma derivatives have an increasing use in the formulation of added health benefit pet food, since the trend is toward humanizing pets and demanding premium quality of pet foods.

Another evidence of the demand for quality pet food can be seen in Canada: more than 0.80 million tons were produced in 2021, and in mid-2022, there was a raise of 19.6% in the import of U.S. pet food. This is the continuing trend in increasing adoption of premium pet food that further fuels demand for bovine blood plasma derivatives.

Analysis of Key Players

The leading players in the medical simulation market include ANZCO Foods (Itoham Yonekyu Holdings), Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare), Moregate Biotech (ANZCO Foods), Proliant Health & Biologicals, LAMPIRE Biological Lab Inc., Rocky Mountain Biologicals, Thermo Fisher Scientific, Inc., Sigma-Aldrich (Merck KGaA), Kraeber & Co GmbH, and Lake Immunogenics

Each of these players have been have been profiled in the bovine blood plasma derivatives market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Bovine Blood Plasma Derivatives Market

  • In June 2024, Dyadic International, Inc. announced that they had entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition, and cell culture markets. According to the terms of the agreement, Dyadic will receive an upfront milestone payment of $1.5Mn and have agreed to a share of profits received by PHB from the sale of animal-free recombinant albumin products produced using Dyadic’s filamentous fungal microbial platforms.
  • In June 2023, Proliant Health & Biologicals and LAMPIRE Biological Laboratories, a global provider of biopharmaceutical and diagnostic testing products, announced a strategic partnership to enhance service offerings for customers in the life sciences industry. This collaboration marks a significant step forward for both the companies, enabling them to provide tailored BSA solutions to meet the specific needs of customers requiring custom formulations and smaller package sizes.

Bovine Blood Plasma Derivatives Market Snapshot

Attribute Detail
Size in 2023 US$ 2.0 Bn
Forecast Value in 2034 More than US$ 3.7 Bn
CAGR 5.8%
Forecast Period 2024-2034
Historical Data Available for 2018-2022
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation
  • By Product
    • Kits and Reagents
    • Instruments
    • Software and Service
  • By Technology
    • Molecular Diagnostics
    • Hematology
    • Immunodiagnostics
    • Others (Cell culture, etc.)
  • By Derivative Type
    • Immunoglobulin
    • Fibrinogen
    • Serum Albumin
    • Fetal Bovine Serum
    • Thrombin
    • Transferrin
    • Others (BGG, etc)
  • By Source
    • US Grade
    • Australia Grade
    • New Zealand Grade
    • Others
  • By End-user Industry
    • Veterinary Industry
      • Veterinary Hospitals
      • Veterinary Reference Laboratories
      • POC/In House Testing
      • Veterinary Research laboratories
    • Food Industry
    • Academic and Research Institutes
    • Cell Culture/ Biotechnology
    • Cosmetic Industry
    • Pharmaceutical Industry
    • Diagnostics Industry
    • Others (Nutrition Supplements, CROs, etc.)
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Benelux
  • Nordic Countries
  • China
  • India
  • Japan
  • South Korea
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
  • Turkey
Companies Profiled
  • ANZCO Foods (Itoham Yonekyu Holdings)
  • Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare)
  • Moregate Biotech (ANZCO Foods)
  • Proliant Health & Biologicals
  • LAMPIRE Biological Laboratories, Inc.
  • Rocky Mountain Biologicals
  • Thermo Fisher Scientific, Inc.
  • Sigma-Aldrich (Merck KGaA)
  • Kraeber & Co GmbH
  • Auckland BioSciences
  • Lake Immunogenics
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global bovine blood plasma derivatives market in 2023?

The global bovine blood plasma derivatives market was valued at US$ 2.0 Bn in 2023

How big will the bovine blood plasma derivatives business be in 2034?

The bovine blood plasma derivatives business is projected to reach more than US$ 3.7 Bn by the end of 2034

What are the factors driving the global bovine blood plasma derivatives market?

Advances in technology for blood collection and processing and increasing demand for advanced drug delivery systems

What will be the CAGR of the bovine blood plasma derivatives industry during the forecast period?

The CAGR is anticipated to be 5.8% from 2024 to 2034

Which region will account for a major share of the bovine blood plasma derivatives sector during the forecast period?

North America is expected to account for the largest share from 2024 to 2034

Who are the prominent bovine blood plasma derivatives providers?

ANZCO Foods (Itoham Yonekyu Holdings), Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare), Moregate Biotech (ANZCO Foods), Proliant Health & Biologicals, LAMPIRE Biological Laboratories, Inc., Rocky Mountain Biologicals, Thermo Fisher Scientific, Inc., Sigma-Aldrich (Merck KGaA), Kraeber & Co GmbH, and Lake Immunogenics

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bovine Blood Plasma Derivatives Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, 2020-2034

        4.4.1. Market Revenue Projections (US$ Bn)

        4.4.2. Market Volume/Unit Shipments Projections

    4.5. Porter’s Five Forces Analysis

5. Key Insights

    5.1. Value Chain Analysis

        5.1.1. Prominent Companies in Bovine Blood Plasma Derivatives Value Chain

        5.1.2. List of Key End-user

    5.2. Porters Five Forces of Analysis

    5.3. Price trend of raw material bovine plasma from 2010-2030

    5.4. Global Bovine Blood Plasma Derivatives: Demand and Supply Scenario

    5.5. Regulatory Scenarios

    5.6. Key Industry Events

    5.7. Technology Overview

        5.7.1. Overview of Bovine Blood Plasma Derivatives Process

            5.7.1.1. Bovine Serum Albumin (BSA)

            5.7.1.2. Immunoglobulin

            5.7.1.3. Fetal Bovine Serum (FBS)

            5.7.1.4. Technology -Summary of blood collection and processing methods

        5.7.2. Overview of Bovine Blood Plasma Yield

    5.8. Distributors Landscape

    5.9. Major Brand Analysis

    5.10. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product, 2020-2034

        6.3.1. Kits and Reagents

        6.3.2. Instruments

        6.3.3. Software and Service

    6.4. Market Attractiveness Analysis, by Product

7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Technology

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Technology, 2020-2034

        7.3.1. Molecular Diagnostics

        7.3.2. Hematology

        7.3.3. Immunodiagnostics

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by Technology

8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Derivative Type

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Derivative Type, 2020-2034

        8.3.1. Immunoglobulin

        8.3.2. Fibrinogen

        8.3.3. Serum Albumin

        8.3.4. Fetal Bovine Serum

        8.3.5. Thrombin

        8.3.6. Transferrin

        8.3.7. Others

    8.4. Market Attractiveness Analysis, by Derivative Type

9. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Source

    9.1. Introduction & Definition

    9.2. Key Findings/Developments

    9.3. Market Value Forecast, by Source, 2020-2034

        9.3.1. US Grade

        9.3.2. Australia Grade

        9.3.3. New Zealand Grade

        9.3.4. Others

    9.4. Market Attractiveness Analysis, by Source

10. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by End-user

    10.1. Introduction & Definition

    10.2. Key Findings/Developments

    10.3. Market Value Forecast, by End-user, 2020-2034

        10.3.1. Veterinary Industry

            10.3.1.1. Veterinary Hospitals

            10.3.1.2. Veterinary Reference Laboratories

            10.3.1.3. POC/In House Testing

            10.3.1.4. Veterinary Research laboratories

        10.3.2. Food Industry

        10.3.3. Academic and Research Institutes

        10.3.4. Cell Culture/ Biotechnology

        10.3.5. Cosmetic Industry

        10.3.6. Pharmaceutical Industry

        10.3.7. Diagnostics Industry

        10.3.8. Others

    10.4. Market Attractiveness Analysis, by End-user

11. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Region

    11.1. Key Findings

    11.2. Market Value Forecast, by Region, 2020-2034

        11.2.1. North America

        11.2.2. Europe

        11.2.3. Asia Pacific

        11.2.4. Latin America

        11.2.5. Middle East & Africa

    11.3. Market Attractiveness Analysis, by Region

12. North America Bovine Blood Plasma Derivatives Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2020-2034

        12.2.1. Kits and Reagents

        12.2.2. Instruments

        12.2.3. Software and Service

    12.3. Market Value Forecast, by Technology, 2020-2034

        12.3.1. Molecular Diagnostics

        12.3.2. Hematology

        12.3.3. Immunodiagnostics

        12.3.4. Others

    12.4. Market Value Forecast, by Derivative Type, 2020-2034

        12.4.1. Immunoglobulin

        12.4.2. Fibrinogen

        12.4.3. Serum Albumin

        12.4.4. Fetal Bovine Serum

        12.4.5. Thrombin

        12.4.6. Transferrin

        12.4.7. Others

    12.5. Market Value Forecast, by Source, 2020-2034

        12.5.1. US Grade

        12.5.2. Australia Grade

        12.5.3. New Zealand Grade

        12.5.4. Others

    12.6. Market Value Forecast, by End-user, 2020-2034

        12.6.1. Veterinary Industry

            12.6.1.1. Veterinary Hospitals

            12.6.1.2. Veterinary Reference Laboratories

            12.6.1.3. POC/In House Testing

            12.6.1.4. Veterinary Research laboratories

        12.6.2. Food Industry

        12.6.3. Academic and Research Institutes

        12.6.4. Cell Culture/ Biotechnology

        12.6.5. Cosmetic Industry

        12.6.6. Pharmaceutical Industry

        12.6.7. Diagnostics Industry

        12.6.8. Others

    12.7. Market Value Forecast, by Country, 2020-2034

        12.7.1. U.S.

        12.7.2. Canada

    12.8. Market Attractiveness Analysis

        12.8.1. By Product

        12.8.2. By Technology

        12.8.3. By Derivative Type

        12.8.4. By Source

        12.8.5. By End-user

        12.8.6. By Country

13. Europe  Bovine Blood Plasma Derivatives Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2020-2034

        13.2.1. Kits and Reagents

        13.2.2. Instruments

        13.2.3. Software and Service

    13.3. Market Value Forecast, by Technology, 2020-2034

        13.3.1. Molecular Diagnostics

        13.3.2. Hematology

        13.3.3. Immunodiagnostics

        13.3.4. Others

    13.4. Market Value Forecast, by Derivative Type, 2020-2034

        13.4.1. Immunoglobulin

        13.4.2. Fibrinogen

        13.4.3. Serum Albumin

        13.4.4. Fetal Bovine Serum

        13.4.5. Thrombin

        13.4.6. Transferrin

        13.4.7. Others

    13.5. Market Value Forecast, by Source, 2020-2034

        13.5.1. US Grade

        13.5.2. Australia Grade

        13.5.3. New Zealand Grade

        13.5.4. Others

    13.6. Market Value Forecast, by End-user, 2020-2034

        13.6.1. Veterinary Industry

            13.6.1.1. Veterinary Hospitals

            13.6.1.2. Veterinary Reference Laboratories

            13.6.1.3. POC/In House Testing

            13.6.1.4. Veterinary Research laboratories

        13.6.2. Food Industry

        13.6.3. Academic and Research Institutes

        13.6.4. Cell Culture/ Biotechnology

        13.6.5. Cosmetic Industry

        13.6.6. Pharmaceutical Industry

        13.6.7. Diagnostics Industry

        13.6.8. Others

    13.7. Market Value Forecast, by Country/Sub-region, 2020-2034

        13.7.1. Germany

        13.7.2. UK

        13.7.3. France

        13.7.4. Italy

        13.7.5. Spain

        13.7.6. Rest of Europe

    13.8. Market Attractiveness Analysis

        13.8.1. By Product

        13.8.2. By Technology

        13.8.3. By Derivative Type

        13.8.4. By Source

        13.8.5. By End-user

        13.8.6. By Country/Sub-region

14. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2020-2034

        14.2.1. Kits and Reagents

        14.2.2. Instruments

        14.2.3. Software and Service

    14.3. Market Value Forecast, by Technology, 2020-2034

        14.3.1. Molecular Diagnostics

        14.3.2. Hematology

        14.3.3. Immunodiagnostics

        14.3.4. Others

    14.4. Market Value Forecast, by Derivative Type, 2020-2034

        14.4.1. Immunoglobulin

        14.4.2. Fibrinogen

        14.4.3. Serum Albumin

        14.4.4. Fetal Bovine Serum

        14.4.5. Thrombin

        14.4.6. Transferrin

        14.4.7. Others

    14.5. Market Value Forecast, by Source, 2020-2034

        14.5.1. US Grade

        14.5.2. Australia Grade

        14.5.3. New Zealand Grade

        14.5.4. Others

    14.6. Market Value Forecast, by End-user, 2020-2034

        14.6.1. Veterinary Industry

            14.6.1.1. Veterinary Hospitals

            14.6.1.2. Veterinary Reference Laboratories

            14.6.1.3. POC/In House Testing

            14.6.1.4. Veterinary Research laboratories

        14.6.2. Food Industry

        14.6.3. Academic and Research Institutes

        14.6.4. Cell Culture/ Biotechnology

        14.6.5. Cosmetic Industry

        14.6.6. Pharmaceutical Industry

        14.6.7. Diagnostics Industry

        14.6.8. Others

    14.7. Market Value Forecast, by Country/Sub-region, 2020-2034

        14.7.1. China

        14.7.2. Japan

        14.7.3. India

        14.7.4. Australia & New Zealand

        14.7.5. Rest of Asia Pacific

    14.8. Market Attractiveness Analysis

        14.8.1. By Product

        14.8.2. By Technology

        14.8.3. By Derivative Type

        14.8.4. By Source

        14.8.5. By End-user

        14.8.6. By Country/Sub-region

15. Latin America Bovine Blood Plasma Derivatives Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Product, 2020-2034

        15.2.1. Kits and Reagents

        15.2.2. Instruments

        15.2.3. Software and Service

    15.3. Market Value Forecast, by Technology, 2020-2034

        15.3.1. Molecular Diagnostics

        15.3.2. Hematology

        15.3.3. Immunodiagnostics

        15.3.4. Others

    15.4. Market Value Forecast, by Derivative Type, 2020-2034

        15.4.1. Immunoglobulin

        15.4.2. Fibrinogen

        15.4.3. Serum Albumin

        15.4.4. Fetal Bovine Serum

        15.4.5. Thrombin

        15.4.6. Transferrin

        15.4.7. Others

    15.5. Market Value Forecast, by Source, 2020-2034

        15.5.1. US Grade

        15.5.2. Australia Grade

        15.5.3. New Zealand Grade

        15.5.4. Others

    15.6. Market Value Forecast, by End-user, 2020-2034

        15.6.1. Veterinary Industry

            15.6.1.1. Veterinary Hospitals

            15.6.1.2. Veterinary Reference Laboratories

            15.6.1.3. POC/In House Testing

            15.6.1.4. Veterinary Research laboratories

        15.6.2. Food Industry

        15.6.3. Academic and Research Institutes

        15.6.4. Cell Culture/ Biotechnology

        15.6.5. Cosmetic Industry

        15.6.6. Pharmaceutical Industry

        15.6.7. Diagnostics Industry

        15.6.8. Others

    15.7. Market Value Forecast, by Country/Sub-region, 2020-2034

        15.7.1. Brazil

        15.7.2. Mexico

        15.7.3. Rest of Latin America

    15.8. Market Attractiveness Analysis

        15.8.1. By Product

        15.8.2. By Technology

        15.8.3. By Derivative Type

        15.8.4. By Source

        15.8.5. By End-user

        15.8.6. By Country/Sub-region

16. Middle East & Africa Bovine Blood Plasma Derivatives Market Analysis and Forecast

    16.1. Introduction

        16.1.1. Key Findings

    16.2. Market Value Forecast, by Product, 2020-2034

        16.2.1. Kits and Reagents

        16.2.2. Instruments

        16.2.3. Software and Service

    16.3. Market Value Forecast, by Technology, 2020-2034

        16.3.1. Molecular Diagnostics

        16.3.2. Hematology

        16.3.3. Immunodiagnostics

        16.3.4. Others

    16.4. Market Value Forecast, by Derivative Type, 2020-2034

        16.4.1. Immunoglobulin

        16.4.2. Fibrinogen

        16.4.3. Serum Albumin

        16.4.4. Fetal Bovine Serum

        16.4.5. Thrombin

        16.4.6. Transferrin

        16.4.7. Others

    16.5. Market Value Forecast, by Source, 2020-2034

        16.5.1. US Grade

        16.5.2. Australia Grade

        16.5.3. New Zealand Grade

        16.5.4. Others

    16.6. Market Value Forecast, by End-user, 2020-2034

        16.6.1. Veterinary Industry

            16.6.1.1. Veterinary Hospitals

            16.6.1.2. Veterinary Reference Laboratories

            16.6.1.3. POC/In House Testing

            16.6.1.4. Veterinary Research laboratories

        16.6.2. Food Industry

        16.6.3. Academic and Research Institutes

        16.6.4. Cell Culture/ Biotechnology

        16.6.5. Cosmetic Industry

        16.6.6. Pharmaceutical Industry

        16.6.7. Diagnostics Industry

        16.6.8. Others

    16.7. Market Value Forecast, by Country/Sub-region, 2020-2034

        16.7.1. GCC Countries

        16.7.2. South Africa

        16.7.3. Rest of Middle East & Africa

    16.8. Market Attractiveness Analysis

        16.8.1. By Product

        16.8.2. By Technology

        16.8.3. By Derivative Type

        16.8.4. By Source

        16.8.5. By End-user

        16.8.6. By Country/Sub-region

17. Competition Landscape

    17.1. Market Player - Competition Matrix (By Tier and Size of companies)

    17.2. Market Share Analysis, by Company (2023)

    17.3. Company Profiles

        17.3.1. ANZCO Foods (Itoham Yonekyu Holdings)

            17.3.1.1. Company Overview

            17.3.1.2. Financial Overview

            17.3.1.3. Product Portfolio

            17.3.1.4. Business Strategies

            17.3.1.5. Recent Developments

        17.3.2. Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare)

            17.3.2.1. Company Overview

            17.3.2.2. Financial Overview

            17.3.2.3. Product Portfolio

            17.3.2.4. Business Strategies

            17.3.2.5. Recent Developments

        17.3.3. Moregate Biotech (ANZCO Foods)

            17.3.3.1. Company Overview

            17.3.3.2. Financial Overview

            17.3.3.3. Product Portfolio

            17.3.3.4. Business Strategies

            17.3.3.5. Recent Developments

        17.3.4. Proliant Health & Biologicals

            17.3.4.1. Company Overview

            17.3.4.2. Financial Overview

            17.3.4.3. Product Portfolio

            17.3.4.4. Business Strategies

            17.3.4.5. Recent Developments

        17.3.5. LAMPIRE Biological Laboratories, Inc.

            17.3.5.1. Company Overview

            17.3.5.2. Financial Overview

            17.3.5.3. Product Portfolio

            17.3.5.4. Business Strategies

            17.3.5.5. Recent Developments

        17.3.6. Rocky Mountain Biologicals, LLC

            17.3.6.1. Company Overview

            17.3.6.2. Financial Overview

            17.3.6.3. Product Portfolio

            17.3.6.4. Business Strategies

            17.3.6.5. Recent Developments

        17.3.7. Thermo Fisher Scientific Inc.

            17.3.7.1. Company Overview

            17.3.7.2. Financial Overview

            17.3.7.3. Product Portfolio

            17.3.7.4. Business Strategies

            17.3.7.5. Recent Developments

        17.3.8. Sigma-Aldrich (Merck KGaA)

            17.3.8.1. Company Overview

            17.3.8.2. Financial Overview

            17.3.8.3. Product Portfolio

            17.3.8.4. Business Strategies

            17.3.8.5. Recent Developments

        17.3.9. Kraeber & Co GmbH

            17.3.9.1. Company Overview

            17.3.9.2. Financial Overview

            17.3.9.3. Product Portfolio

            17.3.9.4. Business Strategies

            17.3.9.5. Recent Developments

        17.3.10. Auckland BioSciences

            17.3.10.1. Company Overview

            17.3.10.2. Financial Overview

            17.3.10.3. Product Portfolio

            17.3.10.4. Business Strategies

            17.3.10.5. Recent Developments

        17.3.11. Lake Immunogenics

            17.3.11.1. Company Overview

            17.3.11.2. Financial Overview

            17.3.11.3. Product Portfolio

            17.3.11.4. Business Strategies

            17.3.11.5. Recent Developments

List of Tables

Table 01: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 02: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034

Table 03: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034

Table 04: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034

Table 05: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034

Table 06: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034

Table 07: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Region, 2020-2034

Table 08: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country, 2020-2034

Table 09: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 10: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034

Table 11: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034

Table 12: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034

Table 13: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034

Table 14: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034

Table 15: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 16: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 17: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034

Table 18: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034

Table 19: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034

Table 20: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034

Table 21: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034

Table 22: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 23: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 24: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034

Table 25: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034

Table 26: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034

Table 27: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034

Table 28: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034

Table 29: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 30: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 31: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034

Table 32: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034

Table 33: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034

Table 34: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034

Table 35: Latin america Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034

Table 36: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 37: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Product, 2020-2034

Table 38: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Technology, 2020-2034

Table 39: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Derivatives Type, 2020-2034

Table 40: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Source, 2020-2034

Table 41: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by End-use Industry, 2020-2034

Table 42: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, by Veterinary Industry, 2020-2034

List of Figures

Figure 01: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast, 2020-2034

Figure 02: Global Bovine Blood Plasma Derivatives Market Value Share, by Product, 2023

Figure 03: Global Bovine Blood Plasma Derivatives Market Value Share, by Technology, 2023

Figure 04: Global Bovine Blood Plasma Derivatives Market Value Share, by Derivatives Type, 2023

Figure 05: Global Bovine Blood Plasma Derivatives Market Value Share, by Source, 2023

Figure 06: Global Bovine Blood Plasma Derivatives Market Value Share, by End-use Industry, 2023

Figure 07: Global Bovine Blood Plasma Derivatives Market Value Share, by Region, 2023

Figure 08: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 09: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Product, 2023

Figure 10: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Product, 2034

Figure 11: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034

Figure 12: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Kits and Reagents, 2020‒2034

Figure 13: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Kits and Reagents, 2023 and 2034

Figure 14: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Instruments, 2020‒2034

Figure 15: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Instruments, 2023 and 2034

Figure 16: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Software and Service, 2020‒2034

Figure 17: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Software and Service, 2023 and 2034

Figure 18: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034

Figure 19: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Technology, 2023

Figure 20: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Technology, 2034

Figure 21: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034

Figure 22: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Molecular Diagnostics, 2020‒2034

Figure 23: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Molecular Diagnostics, 2023 and 2034

Figure 24: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Hematology, 2020‒2034

Figure 25: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Hematology, 2023 and 2034

Figure 26: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Immunodiagnostics, 2020‒2034

Figure 27: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Immunodiagnostics, 2023 and 2034

Figure 28: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Others, 2020‒2034

Figure 29: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Others, 2023 and 2034

Figure 30: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034

Figure 31: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Derivatives Type, 2023

Figure 32: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Derivatives Type, 2034

Figure 33: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034

Figure 34: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Immunoglobulin, 2020‒2034

Figure 35: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Immunoglobulin, 2023 and 2034

Figure 36: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Fibrinogen, 2020‒2034

Figure 37: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Fibrinogen, 2023 and 2034

Figure 38: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Serum Albumin, 2020‒2034

Figure 39: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Serum Albumin, 2023 and 2034

Figure 40: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Fetal Bovine Serum, 2020‒2034

Figure 41: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Fetal Bovine Serum, 2023 and 2034

Figure 42: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Thrombin, 2020‒2034

Figure 43: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Thrombin, 2023 and 2034

Figure 44: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Transferrin, 2020‒2034

Figure 45: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Transferrin, 2023 and 2034

Figure 46: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Others, 2020‒2034

Figure 47: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Others, 2023 and 2034

Figure 48: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034

Figure 49: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Source, 2023

Figure 50: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Source, 2034

Figure 51: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034

Figure 52: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by US Grade, 2020‒2034

Figure 53: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by US Grade, 2023 and 2034

Figure 54: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Australia Grade, 2020‒2034

Figure 55: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Australia Grade, 2023 and 2034

Figure 56: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by New Zealand Grade, 2020‒2034

Figure 57: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by New Zealand Grade, 2023 and 2034

Figure 58: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Others, 2020‒2034

Figure 59: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Others, 2023 and 2034

Figure 60: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034

Figure 61: Global Bovine Blood Plasma Derivatives Market Share Analysis, by End-use Industry, 2023

Figure 62: Global Bovine Blood Plasma Derivatives Market Share Analysis, by End-use Industry, 2034

Figure 63: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034

Figure 64: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Veterinary Industry, 2020‒2034

Figure 65: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Veterinary Industry, 2023 and 2034

Figure 66: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Food Industry, 2020‒2034

Figure 67: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Food Industry, 2023 and 2034

Figure 68: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Academic and Research Institutes, 2020‒2034

Figure 69: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Academic and Research Institutes, 2023 and 2034

Figure 70: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Cell Culture/ Biotechnology, 2020‒2034

Figure 71: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Cell Culture/ Biotechnology, 2023 and 2034

Figure 72: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Cosmetic Industry, 2020‒2034

Figure 73: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Cosmetic Industry, 2023 and 2034

Figure 74: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Pharmaceutical Industry, 2020‒2034

Figure 75: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Pharmaceutical Industry, 2023 and 2034

Figure 76: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Diagnostics Industry, 2020‒2034

Figure 77: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Diagnostics Industry, 2023 and 2034

Figure 78: Global Bovine Blood Plasma Derivatives Market Value (US$ Bn), by Others, 2020‒2034

Figure 79: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Others, 2023 and 2034

Figure 80: Global Bovine Blood Plasma Derivatives Market Value Share Analysis, by Region, 2023 and 2034

Figure 81: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Region, 2023

Figure 82: Global Bovine Blood Plasma Derivatives Market Share Analysis, by Region, 2034

Figure 83: Global Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Region, 2023-2034

Figure 84: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 85: North America Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country, 2023 and 2034

Figure 86: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country, 2024-2034

Figure 87: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 88: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034

Figure 89: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034

Figure 90: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034

Figure 91: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034

Figure 92: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034

Figure 93: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034

Figure 94: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034

Figure 95: North America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034

Figure 96: North America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034

Figure 97: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 98: Europe Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 99: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 100: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 101: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034

Figure 102: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034

Figure 103: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034

Figure 104: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034

Figure 105: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034

Figure 106: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034

Figure 107: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034

Figure 108: Europe Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034

Figure 109: Europe Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034

Figure 110: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 111: Asia Pacific Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 112: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 113: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 114: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034

Figure 115: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034

Figure 116: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034

Figure 117: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034

Figure 118: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034

Figure 119: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034

Figure 120: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034

Figure 121: Asia Pacific Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034

Figure 122: Asia Pacific Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034

Figure 123: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 124: Latin America Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 125: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 126: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 127: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034

Figure 128: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034

Figure 129: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034

Figure 130: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034

Figure 131: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034

Figure 132: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034

Figure 133: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034

Figure 134: Latin America Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034

Figure 135: Latin America Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034

Figure 136: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 137: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 138: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 139: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034

Figure 140: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Product, 2024-2034

Figure 141: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Technology, 2023 and 2034

Figure 142: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Technology, 2024-2034

Figure 143: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Derivatives Type, 2023 and 2034

Figure 144: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivatives Type, 2024-2034

Figure 145: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by Source, 2023 and 2034

Figure 146: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Source, 2024-2034

Figure 147: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Bn) Share Analysis, by End-use Industry, 2023 and 2034

Figure 148: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by End-use Industry, 2024-2034

Copyright © Transparency Market Research, Inc. All Rights reserved